Literature DB >> 21741111

Community-associated meticillin-resistant Staphylococcus aureus strains as a cause of healthcare-associated infection.

J A Otter1, G L French.   

Abstract

Community-associated meticillin-resistant Staphylococcus aureus (CA-MRSA) was first noticed as a cause of infection in community-based individuals without healthcare contact. As the global epidemic of CA-MRSA has continued, CA-MRSA strain types have begun to emerge as a cause of healthcare-associated infections (HAIs) and hospital outbreaks have occurred worldwide. In areas where CA-MRSA clones have become established with high prevalence, for example USA300 (ST8-IV) in the USA, CA-MRSA are beginning to supplant or overtake traditional healthcare-associated MRSA strains as causes of HAI. The emergence of CA-MRSA as a cause of HAI puts a wider group of hospitalised patients, healthcare workers and their community contacts potentially at risk of MRSA infection. It also exposes CA-MRSA strains to the selective pressure of antibiotic use in hospitals, potentially resulting in increased antibiotic resistance, challenges traditional definitions of CA-MRSA and hampers control efforts due to the constant re-introduction of MRSA from an emerging community reservoir. There is thus an urgent need to clarify the definitions, prevalence and epidemiology of CA-MRSA and to develop systems for the identification and control of these organisms in the community, in hospitals and other healthcare facilities, and at the community-hospital interface.
Copyright © 2011 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21741111     DOI: 10.1016/j.jhin.2011.04.028

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  48 in total

1.  Predictors of hospitals with endemic community-associated methicillin-resistant Staphylococcus aureus.

Authors:  Courtney R Murphy; Lyndsey O Hudson; Brian G Spratt; Kristen Elkins; Leah Terpstra; Adrijana Gombosev; Christopher Nguyen; Paul Hannah; Richard Alexander; Mark C Enright; Susan S Huang
Journal:  Infect Control Hosp Epidemiol       Date:  2013-04-22       Impact factor: 3.254

2.  mecA-positive Staphylococcus aureus with low-level oxacillin MIC in Taiwan.

Authors:  Feng-Jui Chen; I-Wen Huang; Chen-Her Wang; Pei-Chen Chen; Hui-Yin Wang; Jui-Fen Lai; Yih-Ru Shiau; Tsai-Ling Yang Lauderdale
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

3.  Whole-genome sequencing for outbreak investigations of methicillin-resistant Staphylococcus aureus in the neonatal intensive care unit: time for routine practice?

Authors:  Taj Azarian; Robert L Cook; Judith A Johnson; Nilmarie Guzman; Yvette S McCarter; Noel Gomez; Mobeen H Rathore; J Glenn Morris; Marco Salemi
Journal:  Infect Control Hosp Epidemiol       Date:  2015-05-08       Impact factor: 3.254

4.  Status Report from the Scientific Panel on Antibiotic Use in Dermatology of the American Acne and Rosacea Society: Part 3: Current Perspectives on Skin and Soft Tissue Infections with Emphasis on Methicillin-resistant Staphylococcus aureus, Commonly Encountered Scenarios when Antibiotic Use May Not Be Needed, and Concluding Remarks on Rational Use of Antibiotics in Dermatology.

Authors:  James Q Del Rosso; Ted Rosen; Diane Thiboutot; Guy F Webster; Richard L Gallo; James J Leyden; Clay Walker; George Zhanel; Lawrence Eichenfield
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

Review 5.  Mortality among patients with methicillin-resistant Staphylococcus aureus USA300 versus non-USA300 invasive infections: a meta-analysis.

Authors:  Rajeshwari Nair; Eric Ammann; Matthew Rysavy; Marin L Schweizer
Journal:  Infect Control Hosp Epidemiol       Date:  2013-12-03       Impact factor: 3.254

6.  Emergence of hospital- and community-associated panton-valentine leukocidin-positive methicillin-resistant Staphylococcus aureus genotype ST772-MRSA-V in Ireland and detailed investigation of an ST772-MRSA-V cluster in a neonatal intensive care unit.

Authors:  Gráinne I Brennan; Anna C Shore; Suzanne Corcoran; Sarah Tecklenborg; David C Coleman; Brian O'Connell
Journal:  J Clin Microbiol       Date:  2011-12-21       Impact factor: 5.948

7.  Predicting high prevalence of community methicillin-resistant Staphylococcus aureus strains in nursing homes.

Authors:  Courtney R Murphy; Lyndsey O Hudson; Brian G Spratt; Victor Quan; Diane Kim; Ellena Peterson; Grace Tan; Kaye Evans; Hildy Meyers; Michele Cheung; Bruce Y Lee; Dana B Mukamel; Mark C Enright; Matthew Whealon; Susan S Huang
Journal:  Infect Control Hosp Epidemiol       Date:  2013-01-23       Impact factor: 3.254

8.  Emerging multidrug resistance in community-associated Staphylococcus aureus involved in skin and soft tissue infections and nasal colonization.

Authors:  Grace C Lee; Steven D Dallas; Yufeng Wang; Randall J Olsen; Kenneth A Lawson; James Wilson; Christopher R Frei
Journal:  J Antimicrob Chemother       Date:  2017-09-01       Impact factor: 5.790

9.  Blue light eliminates community-acquired methicillin-resistant Staphylococcus aureus in infected mouse skin abrasions.

Authors:  Tianhong Dai; Asheesh Gupta; Ying-Ying Huang; Margaret E Sherwood; Clinton K Murray; Mark S Vrahas; Tammy Kielian; Michael R Hamblin
Journal:  Photomed Laser Surg       Date:  2013-02-13       Impact factor: 2.796

10.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus isolated in serial cultures from the respiratory tract of children with cystic fibrosis.

Authors:  Duha Al-Zubeidi; Patrick G Hogan; Mary Boyle; Carey-Ann D Burnham; Stephanie A Fritz
Journal:  Pediatr Infect Dis J       Date:  2014-06       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.